Jul 06, 2017
LOS GATOS, CA (July 6, 2017) - XimedicaDx, formerly known as Accel Biotech, is proud to unveil their comprehensive rebranding, which is officially being revealed at the 69th AACC Clinical Lab Expo in San Diego. The change comes in alignment with their acquisition by Ximedica, a leading full service medical technologies development firm, in July of 2016. XimedicaDx maintains Accel Biotech’s comprehensive experience and expertise in in-vitro diagnostics and life science product development as Ximedica’s Diagnostics Center of Excellence....
Jun 12, 2017
LOS GATOS, CA (June 1, 2017) – Ximedica announced on Thursday that with immediate effect, in addition to her continuing corporate responsibilities, Tracy MacNeal will be taking over leadership of Ximedica’s Diagnostic Center of Excellence as President of XimedicaDx (formerly Accel Biotech)....
Jun 07, 2017
Have you heard? Accel Biotech is becoming XimedicaDx – Ximedica’s Diagnostics Center of Excellence!
Accel Biotech was acquired by Ximedica in 2016 and the full integration allows for an expanded presence in diagnostics and life science, in addition to Ximedica’s expertise in medtech product development....
Jun 01, 2017
PROVIDENCE, RI (June 1, 2017) - Ximedica was recently named as one of the 2017 Best Places to Work in Rhode Island, an annual list of the Best Places to Work in Rhode Island sponsored by Providence Business News and Best Companies Group. This statewide survey and awards program is designed to identify, recognize and honor the top 60 best places of employment in Rhode Island, benefiting the state's economy, workforce and businesses. ...
Apr 12, 2017
In November of 2014, SV Life Sciences, a Boston-based private equity firm, acquired a majority stake in Ximedica, enabling the company to execute its growth strategy. SV Life Sciences recently featured Ximedica CEO Randy Barko and the company on their website.
Mar 24, 2017
Accel Biotech, a Ximedica company, will be exhibiting at the American Association for Cancer Research (AACR) Annual Meeting from April 1-5, 2017 in Washington, DC.
Accel will be displaying an example of their work in the oncology space, ApoCell’s ApoStream system....
Mar 20, 2017
"The relocation comes as a result of the company’s extraordinary growth over the past few years, with our most recent acquisition of Accel Biotech, based in Los Gatos, CA, and our past acquisition of Bridge Design in San Francisco. We’re proud to say Ximedica’s workforce has increased to employing 270 people across the U.S. and in Hong Kong,” says Randall S. Barko, Ximedica’s President and Chief Executive Officer....
Mar 06, 2017
Elodie Sollier-Christen, Vortex Biosciences, was selected as the 2017 Innovation Award Winner at SLAS2017 in Washington, DC, for her presentation, Vortex Biosciences Technology for Fast and Label-Free Isolation of Circulating Tumor Cells from Blood Samples.
Vortex Biosciences has developed VTX-1, a fast and simple platform to isolate and collect intact circulating tumor cells (CTCs) directly from whole blood in less than 1.5 hours....
Mar 01, 2017
Ximedica client Accelerate Diagnostics has been granted FDA clearance to market the Accelerate Pheno™ system and Accelerate PhenoTest™ BC kit for identification and antibiotic susceptibility testing of pathogens directly from positive blood culture samples....
Feb 07, 2017
On January 21 - 22, 2017 Ximedica team members Tara Ebsworth, Farzanah Ausaluth, Ayan Bhandari, Marina Aldarondo and Mark Guarraia attended Yale’s Healthcare Hackathon, an event also sponsored by Ximedica. ...